Given that PGRMC proteins are generally overexpressed in many tumor types, we hypothesize that selectively deleting a PGRMC family member from the endometrium with the heterozygous or complete loss of Pten would prevent the development of or reduce the severity of Pten loss-of-function-induced hyperplasia and cancer. This evidence concerns the gene PGRMC1 and cancer.